Skip to main content
. 2005 Jun 13;145(8):1045–1051. doi: 10.1038/sj.bjp.0706283

Figure 1.

Figure 1

The mean (±s.e.m.) accumulation of [11C]carvedilol in control cells (GLC4), MRP containing cells (GLC4/ADR150x) and P-gp containing cells (GLC4/P-gp) in the presence and absence of an MRP1 (MK571) and a P-gp (CsA) modulator (n=3 in duplicate). Significance is depicted by *.